{"SPADE_N_14805": {"Sequence Information": {"Peptide Name": "Ilamycin C", "Sequence": "AXLXXLX", "Sequence Length": 7, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Source": "1. Streptomyces atratus SCSIO ZH16", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Biosynthesis of Ilamycins Featuring Unusual Building Blocks and Engineered Production of Enhanced Anti-Tuberculosis Agents", "Pubmed ID": "28855504", "Reference": "Nat Commun. 2017;8:391", "Author": "Ma J, Huang H, Xie Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28855504"}], "SPADE ID": "SPADE_N_14805", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00019", "Similarity": 1.0, "Sequence": "GTPLALLGGAATGVIGYISNQTCPTTACTRAC"}, {"SPADE_ID": "SPADE_N_00129", "Similarity": 1.0, "Sequence": "RNKLAYNMGHYAGKATIFGLAAWALLA"}, {"SPADE_ID": "SPADE_N_00278", "Similarity": 1.0, "Sequence": "MARVNSLKCALCFIVLILFVQLNCIPETRVMAVELSRVFLQTSSTDCGEPCVYIPCTITALLGCSCLNKVCVRP"}], "Hemolytic Activity": "Human hepatocyte cells HL-7702 (L02):IC50=7.4 µM,Human umbilical vein endothelial cells HUVEC:IC50=33.8 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=>122.9µM),Acinetobacter baumannii ATCC 19606(MIC=>122.9µM),Enterococcus faecalis ATCC 29212(MIC=>122.9µM),Staphylococcus aureus ATCC 29213(MIC=>122.9µM),Staphylococcus aureus MR(MIC=>122.9µM),Micrococcus luteus SC-1(MIC=>122.9µM),Mycobacterium smegmatis mc2-155(MIC=0.12µM),Mycobacterium tuberculosis H37Rv(MIC=9.6µM),Human cervical carcinoma HeLa(IC50=3.3µM),Human hepatocellular carcinoma HepG2(IC50=3.2µM),Human lung carcinoma A549(IC50=3.5µM),Human nasopharyngeal carcinoma CNE2(IC50=6.8µM),Human breast adenocarcinoma MCF-7(IC50=4.5µM)"}}}